Differences in Exposure to Nicotine, Tobacco-Specific Nitrosamines, and Volatile Organic Compounds among Electronic Cigarette Users, Tobacco Smokers, and Dual Users from Three Countries.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Smith (2020)
Nicotine absorption from e-cigarettes over 12 months.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Soar (2019)
Rapid Brain Nicotine Uptake from Electronic Cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Solingapuram (2020)
hydroxyl Radicals in E-Cigarette Vapor and E-Vapor Oxidative Potentials under Different Vaping Patterns.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Son (2019)
Investigating E-Cigarette Particle Emissions and human airway Depositions under Various E-Cigarette-Use Conditions.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Son (2020)
“I cannot live without my vape”: Electronic cigarette user-identified indicators of vaping dependence.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Soule (2020)
Thermodynamic behaviour of an e-cigarette: Investigation of nicotine delivery consistency using nicotine yield.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Soulet (2022)
Nicotine Pouch: awareness, Beliefs, Use, and Susceptibility among Current Tobacco Users in the United States, 2021
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Sparrock (2023)
Prediction of the transport, deposition, and absorption of multicomponent E-cigarette aerosols in a subject-specific mouth-to-G10 human respiratory system.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Sperry (2023)
assessment of cognitive and psychomotor impairment, subjective effects, and blood ThC concentrations following acute administration of oral and vaporized cannabis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Spindle (2021)